Ceftriaxone therapy for staphylococcal osteomyelitis: A review

被引:35
作者
Guglielmo, BJ [1 ]
Luber, AD
Paletta, D
Jacobs, RA
机构
[1] Univ Calif San Francisco, Dept Clin Pharm, Sch Pharm, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Div Infect Dis, Sch Med, San Francisco, CA 94143 USA
关键词
D O I
10.1086/313620
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ceftriaxone, although less active than standard antistaphylococcal agents, is potentially useful in the treatment of osteomyelitis, Thirty-one patients with osteomyelitis due to Staphylococcus aureus were identified, 22 of whom were treated with ceftriaxone and 9 with other agents. Of those patients treated with ceftriaxone, 17 were cured; all treatment failures were associated with chronic osteomyelitis and continued presence of necrotic bone or infected hardware. It is concluded that ceftriaxone is effective in the ambulatory treatment of S, aureus osteomyelitis.
引用
收藏
页码:205 / 207
页数:3
相关论文
共 9 条
[1]  
CHAMBERS HF, 1984, REV INFECT DIS, V6, pS870
[2]   Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10
[3]   ROLE OF PHARMACOKINETICS IN THE OUTCOME OF INFECTIONS [J].
DRUSANO, GL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (03) :289-297
[4]  
HAMILTON RA, 1987, CLIN PHARMACY, V6, P567
[5]   Biliary sludge [J].
Ko, CW ;
Sekijima, JH ;
Lee, SP .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (04) :301-311
[6]  
KUCERS A, 1997, USE ANTIBIOTICS CLIN, P282
[7]   Osteomyelitis [J].
Lew, DP ;
Waldvogel, FA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) :999-1007
[8]   Practice guidelines for community-based parenteral anti-infective therapy [J].
Williams, DN ;
Rehm, SJ ;
Tice, AD ;
Bradley, JS ;
Kind, AC ;
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (04) :787-801
[9]   CLINICAL PHARMACOKINETICS OF CEFTRIAXONE [J].
YUK, JH ;
NIGHTINGALE, CH ;
QUINTILIANI, R .
CLINICAL PHARMACOKINETICS, 1989, 17 (04) :223-235